Articles tagged ‘’

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronisation therapy combined with defibrillation (CRT-D), concludes the latest analysis of the MADIT-CRT (Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy) trial, presented at the European Society of Cardiology’s (ESC) Heart Failure Congress 2011.

Out-of-hospital cardiac arrest (OHCA) accounts for a significant proportion of paediatric mortality, the most prevalent causes being cardiac, according to a prospective population-based study published recently in the Journal of the American College of Cardiology.¹

The connection between weight loss and a beneficial drop in blood pressure has been quantified by a recent German population-based study,¹ presented recently at EuroPRevent 2011 in Geneva.

Patient safety and outcomes during treatment for arrhythmia could be improved by new clinical technologies and data-sharing facilities, designed to assist electrophysiology (EP) teams, according to a recent presentation at the Heart Rhythm Society’s 32nd annual scientific sessions.

Integrating well designed health programmes into companies can improve the overall health and quality of life of employees, as well as increasing the productivity of the work force, according to research presented recently at the EuroPRevent 2011 meeting, Geneva.

There is growing inequality in the proportion of people who die from stroke between different countries in Europe and central Asia, largely due to varying treatment of hypertension, according to a multi-national study published recently in the European Heart Journal.¹

Over £3.7 million will be invested in seven UK research and development projects into personalised medicine, in a joint venture by the Technology Strategy Board and the Medical Research Council.

The surgical removal of the appendix and tonsils before the age of 20 was associated with an increased risk of premature heart attack in a large population study performed in Sweden.¹

The consequences of myocardial infarction (MI) and stroke could be limited by a simple injection, being developed by an international team whose research was published recently in the Early Online Edition of the Proceedings of the National Academy of Science (PNAS).¹

Patients with atrial fibrillation (AF) treated with primary care therapies often do not stabilise sufficiently to keep them out of hospital, despite treatment conforming to guidelines, according to a study¹ published recently in Clinical Research in Cardiology.